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This guide in paediatric clinical research reflects quite accu-
rately the increased consciousness of the necessity as well as
the difficulties of clinical research in children and adolescents.
“Children deserve at least the same access to innovation as
adults” is a basic premise of this multi-author book. The au-
thors specifically address the question for the European
countries in which live over a hundred million children. They
summarize European recommendations which were written
following an intervention of the European Community for
“Better medicines for children”. The European regulation on
better medicines for children intends: (1) to increase the
development of and information on medicinal products for the
paediatric population, (2) to increase marketing authorizations
of medicines for the use in children, and (3) to ensure that
children’s medicines are subject to high quality research and
that children are not subjected to unnecessary clinical trials.
This last point is especially important; it emphasizes the neces-
sity that paediatric researchers must be highly qualified in
identifying age-related differences, which are extremely im-
portant. This is very well addressed in most of the chapters of
the book: children are indeed not a homogeneous population.
Ethical challenges specific to the paediatric population
are well addressed. Rather than supporting a distinction
between therapeutic and non therapeutic research, which is
correctly considered as artificial, the authors stress the
importance of the Helsinki declaration as reference and the
necessity of categorizing studies with regard to importance
of risks and benefits. The use of consent and assent of
children is well discussed and an overview of legal pre-
scriptions in various countries is included. Technical and
methodological issues are discussed as well as the specific
challenges of research in very small children.
The book is a very good guide for paediatric researchers
but also for other scientists interested in these very specific
aspects of paediatric research. Especially the notion that
harmful effects of drugs or interventions may be restricted to
specific developmental periods can not be stressed enough.
It justifies also more non therapeutic research on various
aspects of normal development, which is of permanent
importance for the identification of especially vulnerable
periods. This is a very delicate aspect, which we all should
communicate to the population, because many strong
opponents to paediatric research would at least like to ban
non therapeutic research in children.
To be recommended warmly to everyone involved with
research in children!
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